Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

被引:282
作者
Gires, O
Kohlhuber, F
Kilger, E
Baumann, M
Kieser, A
Kaiser, C
Zeidler, R
Scheffer, B
Ueffing, M
Hammerschmidt, W
机构
[1] GSF, Natl Res Ctr Environm & Hlth, D-81377 Munich, Germany
[2] Inst Clin Mol Biol & Tumor Genet, D-81377 Munich, Germany
[3] Dept Gene Vectors, D-81377 Munich, Germany
[4] Univ Munich, Dept Otorhinolaryngol, D-81377 Munich, Germany
关键词
B lymphocyte; EBV; JAK3; LMP1; STAT protein;
D O I
10.1093/emboj/18.11.3064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Latent membrane protein 1 (LMP1) acts like a permanently activated receptor of the tumor necrosis factor (TNF)-receptor superfamily and is absolutely required for B cell immortalization by Epstein-Barr virus. Molecular and biochemical approaches demonstrated that LMP1 usurps cellular signaling pathways resulting in the induction of NF-kappa B and AP-1 via two C-terminal activating regions. We demonstrate here that a third region encompassing a proline rich sequence within the 33 bp repetitive stretch of LMP1's C-terminus is required for the activation of Janus kinase 3 (JAK3). The interaction of LMP1 and JAK3 leads to the enhanced tyrosine auto/transphosphorylation of JAK3 within minutes after crosslinking of a conditional NGF-R:LMP1 chimera and is a prerequisite for the activation of STAT transcription factors. These results reveal a novel activating region in the LMP1 C-terminus and identify the JAK/STAT pathway as a target of this viral integral membrane protein in B cells.
引用
收藏
页码:3064 / 3073
页数:10
相关论文
共 59 条
  • [1] BAICHWAL VR, 1988, ONCOGENE, V2, P461
  • [2] JAKs and STATs branch out
    Briscoe, J
    Kohlhuber, F
    Muller, M
    [J]. TRENDS IN CELL BIOLOGY, 1996, 6 (09) : 336 - 340
  • [3] Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
    Catlett-Falcone, R
    Landowski, TH
    Oshiro, MM
    Turkson, J
    Levitzki, A
    Savino, R
    Ciliberto, G
    Moscinski, L
    Fernández-Luna, JL
    Nuñez, G
    Dalton, WS
    Jove, R
    [J]. IMMUNITY, 1999, 10 (01) : 105 - 115
  • [4] EPSTEIN-BARR-VIRUS NUCLEAR PROTEIN-2 MUTATIONS DEFINE ESSENTIAL DOMAINS FOR TRANSFORMATION AND TRANSACTIVATION
    COHEN, JI
    WANG, F
    KIEFF, E
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (05) : 2545 - 2554
  • [5] STATs and gene regulation
    Darnell, JE
    [J]. SCIENCE, 1997, 277 (5332) : 1630 - 1635
  • [6] Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells
    Delecluse, HJ
    Hilsendegen, T
    Pich, D
    Zeidler, R
    Hammerschmidt, W
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 8245 - 8250
  • [7] DELECLUSE HJ, 1999, IN PRESS P NATL ACAD
  • [8] Devergne O, 1996, MOL CELL BIOL, V16, P7098
  • [9] Epstein-Barr virus: LMP1 masquerades as an active receptor
    Eliopoulos, AG
    Rickinson, AB
    [J]. CURRENT BIOLOGY, 1998, 8 (06) : R196 - R198
  • [10] Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappa B pathway involving TNF receptor-associated factors
    Eliopoulos, AG
    Stack, M
    Dawson, CW
    Kaye, KM
    Hodgkin, L
    Sihota, S
    Rowe, M
    Young, LS
    [J]. ONCOGENE, 1997, 14 (24) : 2899 - 2916